The mother of this 4-year-old boy is concerned about a small drop of fluid that she noticed on her son’s neck at the dinner table the night before.
Case: The mother of this 4-year-old boy is concerned about a small drop of fluid that she noticed on her son’s neck at the dinner table the night before. When she examined the area closely, she discovered a small opening. Her son tells her that he has been aware of this for a long time, and he wonders why she is suddenly concerned.
Is his mother’s concern warranted? Is this discovery a sign of a more ominous developmental problem?
No. A branchial cleft sinus is almost always an isolated defect.
This boy has a branchial cleft sinus-a minor developmental defect that is thought to result from improper closure of one of the embryonic branchial clefts. These defects may appear along a line extending from the preauricular skin to the mandible and then down the lateral neck. They occur most commonly in the lower third of the lateral neck on the anterior border of the sternocleidomastoid muscle-as in this child. It is said that approximately 10% are bilateral. The majority of these sinus tracts are blind, but some may drain into the pharynx. Branchial cleft sinuses are virtually always isolated events.
Diagnosis. Typically, a branchial cleft sinus is first noticed at birth or in early childhood when a small amount of mucus discharge is discovered on the skin in association with a small ostium in a typical location. In older children and adults, these defects may first present as cysts that may become inflamed or infected on a recurrent basis.
Treatment. Treatment of a branchial cleft sinus consists of complete surgical removal of the sinus, its tract, and any associated fistulas. Removal obviates the possibility of chronic infections or cyst formation. Before surgery, most surgeons explore the extent of the sinus radiologically.
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.
Pz-cel granted FDA Priority Review to treat recessive dystrophic epidermolysis bullosa
November 28th 2023The FDA granted Priority Review to pz-cel following a phase 1/2 and a pivotal phase 3 study in which the treatment for recessive dystrophic epidermolysis bullosa (RDEB) demonstrated wound healing and pain reduction.
IDP-126 topical gel approved by FDA to treat acne in patients 12 years and up
October 21st 2023The topical gel is the first and only FDA-approved triple-combination, fixed-dose topical treatment for acne, and is set to be available in the first quarter of 2024, according to Bausch Health Companies Inc.
A 13-year-old girl with well-demarcated rash on back and chest
October 19th 2023A healthy 13-year-old girl presented with a 1-month history of an asymptomatic, well-demarcated rash on her back and upper chest. The eruption consisted of discrete, dark brown papules that coalesced into large, flat-topped plaques with mild superficial scale and accentuation of skin markings. What's the diagnosis?